Ballantyne Charles Evan
Insider CIK 1371742 · AGEN Chief Financial Officer · GANX Chief Financial Officer · SYN Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GANX Gain Therapeutics, Inc. | A Award deriv | 2023-04-10 | 2023-04-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2023-04-10 | 2023-04-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2016-06-14 | 2016-06-16 | 75,000 | $4.16 | $312.0K | 75,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2016-06-14 | 2016-06-16 | 14,000 | — | $0 | 14,000 | SEC↗ |
| AGEN AGENUS INC | A Award | 2016-04-26 | 2016-04-28 | 21,683 | $4.15 | $90.0K | 21,683 | SEC↗ |
| AGEN AGENUS INC | D To issuer | 2016-04-26 | 2016-04-28 | 7,035 | $4.15 | $29.2K | 14,648 | SEC↗ |
| AGEN AGENUS INC | D To issuer | 2016-04-26 | 2016-05-13 | 7,107 | $4.15 | $29.5K | 24,795 | SEC↗ |
| AGEN AGENUS INC | A Award | 2016-04-26 | 2016-05-13 | 21,902 | $4.15 | $90.9K | 31,902 | SEC↗ |
| AGEN AGENUS INC | P Buy | 2015-09-25 | 2015-09-29 | 10,000 | $5.05 | $50.5K | 10,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2015-06-17 | 2015-06-17 | 150,000 | $9.78 | $1.47M | 150,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2015-01-08 | 2015-01-12 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | P Buy | 2014-05-22 | 2014-05-27 | 10,000 | $1.35 | $13.5K | 10,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2014-04-17 | 2014-04-21 | 150,000 | — | $0 | 150,000 | SEC↗ |